In contrast, we found higher numbers of T cells expressing CD62L and CXCR3 in the periphery, the latter which has recently been shown to be required for CD8+ T-cell trafficking towards melanomas in vivo35 (Fig. 1c). The gene discussed is SELL; the disease is melanoma.